News

Stocks Surge on International Markets

1 Mins read

The trading day ended on a positive note for international stocks in New York. The S&P/BNY Mellon index of American depositary receipts witnessed a significant 2% increase, reaching a high of 156.16. Similarly, the European index saw a positive trend with a 1.9% rise to 150.29. Asia also experienced a boost with the Asian index rising by 2.2% to 181.67. Latin American stocks showed a slight improvement as the Latin American index edged up by 0.6% to 205.65. The emerging-markets index rose by 2% to reach an impressive 303.41.

RedHill Biopharma stood out among actively traded ADRs during the day. The specialty biopharmaceutical company witnessed a staggering 27% surge in its stock price following its latest earnings report. The report highlighted a nearly 10% increase in new prescriptions of Talicia compared to the previous year. Dror Ben-Asher, Chief Executive of RedHill Biopharma, expressed optimism for the company’s future commercial endeavors, particularly focusing on maximizing the potential of Talicia.

EHang Holdings also experienced an upward trend in its stock price, as it climbed a remarkable 20%. This surge came after the announcement that the autonomous aerial vehicle technology platform company successfully secured a $23 million private placement through share subscription agreements with several strategic investors.

Overall, this bullish trading session indicates positive prospects for international stocks, as various sectors and regions demonstrated notable gains. Investors eagerly await further developments in these companies and their respective markets.

Related posts
News

Your Social Security Checks are Safe

2 Mins read
Don’t worry, the impending federal government shutdown will not put your monthly Social Security checks in jeopardy. This is certainly a relief…
News

European Stocks Experience Decrease

1 Mins read
The European stock market saw a decline on Friday, with the Stoxx Europe 600 index finishing down 0.31% at 453.26. Individual Index…
News

Positive Results for Cancer-Drug Combination in Bladder Cancer Study

1 Mins read
A recent Phase 3 study conducted by Merck & Co., Seagen, and Astellas Pharma has achieved its primary goals in certain patients…

Leave a Reply

Your email address will not be published. Required fields are marked *